Skip to content
Main Menu
  • Home
  • About
  • News
  • Working with us
  • Contact Us

Tag: Darzalex Faspro

EHA: Johnson & Johnson, bolsters Darzalex’s myeloma lead with ‘unprecedented’ survival data

myeloma

Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. Adding Darzalex to Bristol Myers Squibb’s Revlimid and […]

SENGLOBAL

Sign Up For the Latest  from Senglobal News

Headlines and summaries of the latest Science News articles, delivered to your inbox

© 2025 Senglobalcoms © All rights reserved
Facebook Instagram Twitter Linkedin